Eric Topol/LinkedIn
May 31, 2026, 15:41
Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Xiaqing Jiang et al., published in The Lancet, adding:
”The p-tau217 breakthrough blood test replicated again, predicting Alzheimer’s disease in a large cohort mean age 61.
The cover of the new issue is telling.”
Title: Alzheimer’s disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study
Authors: Xiaqing Jiang, Tina D Hoang, Prof Leslie M Shaw, Prof David R Jacobs, Ilya M Nasrallah, Prof R Nick Bryan, Prof Kristine Yaffe
Other posts featuring Eric Topol on Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough